Innovation focused on addressing unmet medical need and improving outcomes for patients is one of the central and overarching goals of the life sciences sector, with significant contributions from large biopharmaceutical companies, biotech and specialty pharma companies, drug delivery companies, and academia. For decades the
creation of new medicines has increased quality and quantity of life for patients around the globe. Just looking at the past decade reveals great
progress on various fronts, including a 40% reduction of cardiovascular deaths in the US, a significant increase of life expectancy of HIV
patients, and the advent of cancer medicine–diagnostic combinations, among others [1]. Scientific breakthroughs leading to novel and
valuable medicines are benefiting both patients and their caregivers, and ultimately, society.
read more